Hightower Clinical in Oklahoma City is actively conducting research to explore new and innovative treatments for a variety of conditions. These trials aim to advance scientific knowledge, improve patient outcomes, and develop safer, more effective therapies.
Upcoming Studies
Advancing Care for Hereditary Hemochromatosis Through Research
Hereditary Hemochromatosis (HH) is a genetic condition in which the body absorbs and stores too much iron. Over time, excess iron can build up in organs such as the liver, heart, pancreas, and joints, causing complications like liver disease, diabetes, fatigue, and joint pain. Understanding HH through research is essential for developing better treatments and improving patient outcomes.
Hightower Clinical is set to conduct a research study focused on evaluating the safety and effectiveness of an investigational treatment for HH. The study aims to reduce iron overload, manage symptoms, and help prevent long-term organ damage.
If you or a loved one has Hereditary Hemochromatosis, this study provides an opportunity to explore potential treatment options under expert medical care.
Condition
Hereditary Hemochromatosis
Current Status
Upcoming
Location
Oklahoma
Potential Access to Advanced Lung Cancer Research
Lung cancer remains one of the most serious and deadly cancers worldwide, and early detection, treatment, and research are critical to improving outcomes. Patients diagnosed with lung cancer often face challenges in accessing personalized care and contributing to research that may advance future therapies.
Hightower Clinical is offering participation in a Lung Cancer Biorepository study, designed to collect blood, tissue, and other biological samples from patients with lung cancer. Contributions to the biorepository help researchers better understand the disease, identify new biomarkers, and develop targeted therapies. Participants may gain access to cutting-edge research and support the advancement of innovative lung cancer treatments.
Condition
Lung Cancer
Current Status
Upcoming
Location
Oklahoma
Heart Failure Research: A Potential New Approach to Treatment
Heart failure is a chronic condition where the heart cannot pump blood efficiently, leading to symptoms like shortness of breath, fatigue, and fluid retention. It can result from weakened heart muscles, high blood pressure, or coronary artery disease. While lifestyle changes, medications, and procedures help manage the condition, researchers are continuously working on better treatment options.
Hightower Clinical is conducting a study to evaluate the effect of an investigational treatment for individuals with heart failure with preserved or mildly reduced ejection fraction and obesity. This study aims to determine if the treatment can reduce heart-related complications, including cardiovascular death and hospitalizations. If you or a loved one qualifies, enrolling in this study could provide access to a potential new treatment while contributing to vital research.
Contact Hightower Clinical today to learn more.
Condition
Heart Failure
Current Status
Upcoming
Location
Oklahoma
Exploring Potential New Treatments for Managing Blood Pressure
Hightower Clinical is conducting a new research study to evaluate a novel feature in Medtronic dual-chamber pacemakers that may help improve blood pressure control. This feature, called AVIM (atrioventricular interval modulation), is designed to work alongside your current pacemaker settings. The goal is to assess whether this added technology can safely and effectively support better heart function and blood pressure management.
This study is open to individuals who already have a Medtronic Astra or Azure pacemaker or are scheduled to receive one soon. If you are also living with uncontrolled high blood pressure, you may be eligible to participate. The study involves continued use of your usual medications, along with close monitoring and support from our clinical team.
Condition
Hypertension
Current Status
Upcoming
Location
Oklahoma
Assessing the Potential of a Drug Eluting Balloon in Treating SFA Stenosis
Hightower Clinical is soon conducting a research study for people with peripheral arterial disease (PAD) affecting the superficial femoral artery (SFA) and proximal popliteal artery (PPA). The study will compare a new treatment, a drug-eluting balloon (DEB), to a standard uncoated balloon used in angioplasty procedures.
This research aims to find out if the new balloon treatment is safer and more effective in improving blood flow. Participants will be randomly assigned to one of the two treatment options, and care will be provided by experienced physicians at no cost to them.
Condition
Superficial Femoral Artery (SFA) Stenosis
Current Status
Upcoming
Location
Oklahoma
